Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05752344
Other study ID # 3499
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date November 1, 2022

Study information

Verified date February 2023
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The target population of this observational study is made up of all patients belonging to the Interstitial Cystitis pathway of the Gemelli University Hospital Foundation - IRCCS, who have accepted to be subjected to remote monitoring and diagnostic investigation. The aim of the study is the evaluation of some outcome parameters at the time of enrollment (T0), and at the end (T1) of subjects affected by Intersitial Cystitis who have carried out a monitoring of the dimensions of the psychic sphere concerning: depression, trait anxiety, state anxiety , well-being, self-efficacy, resilience.The objective is also to evaluate the presence of evolutionary and maturational trends in the mental set-up of the people who participated in the individual counseling intervention.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date November 1, 2022
Est. primary completion date February 1, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Recruited subjects have a diagnosis of Interstitial Cystitis and are 18 years of age or older. Exclusion Criteria: - Previous or current intellectual disability in accordance with the Diagnostic and Statistical Manual of Mental Disorders, DSM-5. - Patients who are unable to express consent and who do not have a caregiver who can give it for them.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Counseling
Professional Counseling is an activity that aims to improve the client's quality of life. Supporting his strengths and his ability to self-determination, Counseling offers a space for listening and reflection in which to explore difficulties, related to evolutionary processes, transition phase, states of crisis and reinforcement of the ability to choose or change.

Locations

Country Name City State
Italy Fondazione Policlinico Gemelli IRCCS Rome Roma

Sponsors (1)

Lead Sponsor Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gastrointestinal Symptom Rating Scale (GSCG) Administration of psychometric scales 12 months
Primary Hospital Anxiety and Depression Scale (HADS) Administration of psychometric scales 12 months
Secondary Psychological General Well-Being Index (PGWBI) Administration of psychometric scales 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT02868775 - A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome N/A
Completed NCT00672087 - Diagnostic Challenges in IC (and Male CPPS)
Completed NCT01482676 - The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction N/A
Terminated NCT00380783 - Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis Phase 2
Completed NCT00775281 - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. N/A
Completed NCT05260112 - Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide N/A
Completed NCT01613586 - A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) Phase 2
Completed NCT02411110 - A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome Phase 2
Recruiting NCT06299683 - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment N/A
Completed NCT00248664 - Events Preceding Interstitial Cystitis (EPIC) N/A
Completed NCT00601484 - An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis Phase 2
Completed NCT02214550 - Chronic Pain Risk Associated With Menstrual Period Pain Phase 4
Completed NCT04275297 - Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome N/A
Terminated NCT00999518 - A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome Phase 2
Completed NCT00675298 - Linkage Analysis in Interstitial Cystitis N/A
Terminated NCT02781103 - Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain N/A
Recruiting NCT01074567 - DMSO Efficacy in IC/PBS Patients During and After Treatment N/A
Completed NCT02497976 - Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis Phase 3
Terminated NCT02787083 - A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis Phase 3
Withdrawn NCT00275379 - Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis N/A